Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In order to understand how gene regulation is achieved in eukaryotes in response to DNA damage, we used budding yeast as a model lower eukaryotic organism and investigated the molecular events leading to the expression of two closely clustered damage-inducible genes, MAG1 and
DDI1
. MAG1 and
DDI1
are co-activated by a shared 8 bp repeat sequence, UAS(DM). In this study, we screened a yeast genomic library, identified Pdr3 as the
transcriptional activator
and demonstrated in vivo and in vitro that Pdr3 binds UAS(DM). Pdr3 is required for the activation of a number of genes encoding membrane efflux pumps and deletion of PDR3 results in reduced basal-level expression and loss of DNA damage induction of MAG1 and
DDI1
. Interestingly, Pdr1, another
transcriptional activator
homologous to Pdr3 that is also required for the activation of multidrug-resistance genes, is not involved in the regulation of MAG1 and
DDI1
expression, although it may also bind to UAS(DM). Deletion of PDR3 does not affect the expression of other well-documented DNA damage-inducible genes; hence, yeast DNA damage-inducible genes appear to have distinct effectors although to a certain extent they share a common regulatory pathway mediated by DNA damage checkpoints.
...
PMID:Pdr3 is required for DNA damage induction of MAG1 and DDI1 via a bi-directional promoter element. 1545 73